Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Ban selling, import of...

    Ban selling, import of smokeless tobacco products: NICPR-ICMR report

    Written by Ruby Khatun Khatun Published On 2018-04-26T16:09:32+05:30  |  Updated On 26 April 2018 4:09 PM IST
    Ban selling, import of smokeless tobacco products: NICPR-ICMR report

    New Delhi: A government body along with the Indian Council of Medical Research (ICMR) has compiled a report that recommends banning the manufacture, selling and import of smokeless tobacco products as per a WHO framework.


    The first-ever compilation of the global progress made in implementing smokeless tobacco control policies was prepared by the National Institute of Cancer Prevention and Research (NICPR) in collaboration with the ICMR.



    The compilation is in line with the World Health Organisation (WHO) Framework Convention on Tobacco Control (FCTC), the cancer research institute said in a statement.


    The NICPR has been designated as a WHO-FCTC global knowledge hub for prevention and control of smokeless tobacco (SLT).



    The use of SLT products, which includes pan masala, gutkha, and khaini, is a serious public health issue in India and the region. Globally there are nearly 36 crore SLT users, the statement said.

    It said that around 80 percent of these live in South-East Asia and 66 percent in India and according to the latest Global Adult Tobacco Survey India Report nearly 20 crore Indians use SLTs.

    The key recommendations are banning of manufacture, selling and importing of such products; organizing awareness programmes; and training to health professionals for providing behavioural interventions, specifically for smokeless tobacco cessation, taxing of such products and preventing their sale to and by minors, the statement said.

    The report was released today by Balram Bhargava, Director General, ICMR, and Secretary, Department of Health Research, Ministry of Health and Family Welfare.

    Bhargava highlighted the dual burden of the tobacco in India and South-East Asia nations such as Bangladesh, Myanmar, and Sri Lanka.

    He said that the report will go a long way in providing guidance to parties on how to implement effective SLT control measures within their jurisdictions, the statement stated.

    A 2010 study estimated that more than 36,8000 deaths were attributable to smokeless tobacco use in the country.

    To address the burden of smokeless tobacco, the Government of India joined hands with the WHO-FCTC Secretariat and set up a global knowledge hub on Smokeless Tobacco (KH-SLT) at the ICMR-NICPR), Noida.

    The WHO FCTC Secretariat initiated and supported the compilation and publication of this report.

    banningframeworkFramework Convention on Tobacco ControlICMRImportIndian Council of Medical ResearchNational Institute of Cancer Prevention and ResearchNICPRrecommendssellingsmokelesstobacco productsWHOWorld Health Organisation
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok